(Abst.) Predictors of risk of secondary progression in MS on: September 16, 2025, 09:08:35 pm #1 Although this was a small study, the topic is one that has been of considerable interest for people with MS.From Therapeutic Advances in Neurological Disorders (September 9, 2025)--"Predictors of risk of secondary progression in multiple sclerosis":https://journals.sagepub.com/doi/full/10.1177/17562864251357276#tab-contributors Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
